HD-tDCS over the dorsal medial prefrontal cortex reduces insomnia severity and improves sleep onset latency and sleep efficiency in chronic insomnia patients
A 10-day regimen of active high-definition transcranial direct current stimulation (HD-tDCS) targeting the bilateral dorsal medial prefrontal cortex significantly decreased Pittsburgh Sleep Quality Index (PSQI) scores compared to sham stimulation in chronic insomnia patients. Exploratory polysomnography findings also showed improvements in sleep onset latency and sleep efficiency after active treatment.
This article is automatically generated from the structured evidence profile behind the claim above. Scores reflect the quality and quantity of available research, not clinical advice.
HD-tDCS over the dorsal medial prefrontal cortex reduces insomnia severity and improves sleep onset latency and sleep efficiency in chronic insomnia patients The current body of evidence comprises 1 study, including 1 randomized controlled trial. EvidenceHub rates the overall confidence at 42/100 (low).
The Claim
HD-tDCS over the dorsal medial prefrontal cortex reduces insomnia severity and improves sleep onset latency and sleep efficiency in chronic insomnia patients
This conclusion is most relevant to: 55 patients with chronic insomnia.
What the Research Shows
The conclusion draws on 1 linked study. Highlights from the cited literature:
- ▸Effects of high-definition transcranial direct current stimulation for the treatment of chronic insomnia: a randomized, double-blind, controlled trial. (Scientific reports, 2025) —
How It Works
The proposed biological pathway:
- ▸Anodal HD-tDCS applied over DMPFC modulates cortical excitability in prefrontal regions
- ▸Enhanced prefrontal control over arousal and sleep-regulating circuits
- ▸Reduction in hyperarousal and maladaptive sleep-related cognition
- ▸Result: Improved sleep initiation and maintenance, reduced insomnia severity
Who Might Benefit
Evidence fit by population:
- ▸55 patients with chronic insomnia
Recommended Dose
10 daily sessions of HD-tDCS
Limitations & Caveats
Important context when interpreting this evidence:
- ▸Small sample size (n=55) limits generalizability
- ▸No long-term follow-up data reported
- ▸Exploratory nature of PSG findings without correction for multiple comparisons
Frequently Asked Questions
What is HD-tDCS and how does it differ from conventional tDCS?▼
HD-tDCS uses a high-definition array of small electrodes (e.g., one anode and four cathodes) to more focally target brain regions, such as the DMPFC, compared to conventional tDCS which uses larger sponge electrodes.
How long does it take for HD-tDCS to improve insomnia symptoms?▼
In this study, improvements were observed after 10 daily sessions of stimulation, with PSQI scores decreasing and sleep onset latency and efficiency improving post-treatment.
Is HD-tDCS safe for chronic insomnia patients?▼
The study reports no adverse effects, but the authors note that additional safety data are needed before it can be recommended as a routine therapy.
Can HD-tDCS replace medication or cognitive behavioral therapy for insomnia?▼
The authors suggest HD-tDCS is a possibly promising supplement to medication and CBT-I, not a replacement, and requires replication.
References
- 1.Li J, Li A, Jiao J, Hu K, Jiang Y, Hu X, Wang K, Chen X, Xie C. “Effects of high-definition transcranial direct current stimulation for the treatment of chronic insomnia: a randomized, double-blind, controlled trial..” Scientific reports, 2025. PMID: 40695876 DOI: 10.1038/s41598-025-09304-4